Why is Amerise BioScie falling/rising?

As of 18-Sep, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at Rs 0.69, which reflects a decrease of Rs 0.05 or 6.76%. The stock has underperformed significantly, with a 1-week return of -8.00% and a 1-month return of -11.54%. Additionally, it is trading below all its moving averages, indicating a bearish trend. The stock is also close to its 52-week low, just 4.35% away from Rs 0.66. Despite a slight increase in delivery volume, which rose by 5.12% against the 5-day average, the overall performance remains weak, as it has underperformed its sector by 7.09%. There are no positive or negative factors provided to further explain the recent movement.
Broader market context shows that while Amerise Biosciences Ltd is struggling, the benchmark Sensex has performed positively, with a 1-week return of +1.80% and a 1-month return of +2.14%. This stark contrast highlights the stock's underperformance relative to the broader market, as it has declined significantly year-to-date by 42.98%, while the Sensex has gained 6.24%. The overall liquidity of the stock remains adequate for trading, but the persistent decline in its price suggests a lack of investor confidence compared to the market's upward trajectory.